Thought Leadership

District of Delaware Finds Allergan Patents Invalid for Lack of Written Description and Obviousness-Type Double Patenting in Allergan v. MSN Labs

Texas Patent Litigation Monthly Wrap-Up: October 2023

District of Delaware Finds Non-Orange Book-Listed Patents Subject to the Same Pleading Standard as Listed Patents in ANDA Infringement Suit

ITC Monthly Wrap-Up: September 2023

Federal Circuit Evaluates Enablement for Antibody Claims for the First Time Since Amgen v. Sanofi in Baxalta Inc. et al. v. Genentech, Inc.

ITC Monthly Wrap-Up: August 2023

Minnesota Patent Litigation Wrap-Up: Q2 2023

ITC Monthly Wrap-Up: July 2023

Texas Patent Litigation Monthly Wrap-Up: June 2023

ITC Monthly Wrap-Up: June 2023

ITC Monthly Wrap-Up: May 2023

Amgen v. Sanofi